Umbilical line

An umbilical line is a catheter that is inserted into one of the two arteries or the vein of the umbilical cord. Generally the UAC/UVC (Umbilical Artery Catheter/Umbilical Vein Catheter) is used in Neonatal Intensive Care Units (NICU) as it provides quick access to the central circulation of premature infants. UAC/UVC lines can be placed at the time of birth and allow medical staff to quickly infuse fluids, inotropic drugs, and blood if required. It is sometimes used in term or near-term newborns in whom the umbilical cord stump is still connected to the circulatory system. Medications, fluids, and blood can be given through this catheter and it allows monitoring of blood gasses and withdrawing of blood samples. Complications include infection and thromboembolism.

Transumbilical catheter intervention is also a method of gaining access to the heart, for example to surgically correct a patent ductus arteriosus.

Umbilical arterial catheter

The position of an umbilical arterial catheter is confirmed on plain film. From the umbilicus, the umbilical arterial catheter dives inferiorly and joins the right or left internal iliac artery before turning superiorly to the common iliac artery and aorta. Appropriate positioning of the catheter tip can be either 'high' or 'low.' The high range is judged relative to thoracic vertebra, and is between T6 and T10, to avoid major aortic branches. The low range is relative to lumbar vertebra, and is between L3 and L5. The lower position may be associated with a higher rate of vascular complications such as thrombosis or vasospasm.

Podcasts:

PLAYLIST TIME:

Latest News for: umbilical line

‘Not your normal salvage operation’: Picking up the pieces after the Key Bridge Collapse

Wtop 25 Mar 2025
... you, but you also have your umbilical” to manage, she said, referring to the cable that runs the oxygen and communication lines between each diver and the teams on the surface of the water.

Graft Versus Host Disease Market Expected to rise, 2034 | Biocon, medac GmbH, MaaT Pharma, ...

GetNews 12 Mar 2025
Graft Versus Host Disease (GVHD) is a significant complication of allogeneic stem cell transplantation, where stem cells are derived from bone marrow, peripheral blood, or umbilical cord blood.

Dermatomyositis Drug Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Treatment Market, Prevalence, Medication, Statistics, ...

GetNews 12 Mar 2025
"Dermatomyositis Drug Market" ... Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its umbilical cord outer lining stem cells (ULSCs) program for the treatment of Polymyositis (PM) and Dermatomyositis (DM) ... (NASDAQ ... IMO-8400.
  • 1
×